Brief: Cann Group Says Acquisition Of Zalm Therapeutics By Rua Bioscience Approved By Rua Shareholders
20/01/2022 02:11
Jan 20 (Reuters) - Cann Group Ltd CAN.AX :
* ACQUISITION OF ZALM THERAPEUTICS BY RUA BIOSCIENCE LTD
APPROVED
BY RUA'S SHAREHOLDERS
Source text for Eikon: ID:nASX1JBTRm
Further company coverage: CAN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth